Quarterly report pursuant to Section 13 or 15(d)

Equity Joint Venture (Details)

v3.8.0.1
Equity Joint Venture (Details) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 24, 2016
Sep. 30, 2017
Sep. 24, 2016
Dec. 31, 2016
Feb. 29, 2016
Schedule of Equity Method Investments [Line Items]            
Operating income $ 0 $ 24 $ 52 $ 57    
Investment: equity method 57   57   $ 59  
Prepayment and other receivables - related parties 26   26   32  
THATIC JV            
Schedule of Equity Method Investments [Line Items]            
Investment: equity method 0   0      
Prepayment and other receivables - related parties 5   5   $ 0  
THATIC JV | Licensing Gain [Member]            
Schedule of Equity Method Investments [Line Items]            
Estimated license fees expected to be earned over several years pursuant to a licensing agreement           $ 293
Operating income 0 24 52 57    
THATIC JV | Royalty income [Member]            
Schedule of Equity Method Investments [Line Items]            
Operating income 0 0 0 0    
THATIC JV | Development fee [Member]            
Schedule of Equity Method Investments [Line Items]            
Development fee, as credit to research and development expense $ 7 $ 0 $ 17 $ 0